It was found that tumor-associated DCs deplete arginine and limit its use in T cells, and DCs metabolize arginine to SPD, further driving tryptophan metabolic enzyme indoleamine-2,3-dioxygenase (IDO) phosphorylation and IDO signaling activation [9]. The gene discussed is IDO1; the disease is neoplasm.